Download Full Text (534 KB)
Opioid use disorder is a major epidemic in the United States. • Rural areas suffer the most with limited resources available for treatments options. • A limited number of providers participate in MAT programs due to a negative stigma. • Project Echo was developed to spread awareness and information about MAT to educate providers and healthcare facilities about the needs of opioid use disorder patients that are not being met. • Buprenorphine, naltrexone, and methadone are the FDA approved medications to assist in MAT. • Medication assisted treatment is a long-term commitment to successfully maintain sobriety. • Medication alone is not a reliable means of achieving nor maintaining sobriety. • Cognitive behavioral therapy has proven to be a key factor in battling opioid use disorder (OUD).
Physician Assistant Studies
Date of Work
Opioid, oxycodone, heroin, Medication Assisted Treatment (MAT), Buprenorphine, naltrexone, methadone, agonists
Medicine and Health Sciences
Myklebust, Casey, "MAT Effectiveness for Oxycodone vs Heroin in Opioid Use Disorders" (2020). Physician Assistant Scholarly Project Posters. 212.